Humana Press, Methods in Molecular Biology, p. 187-207
DOI: 10.1007/978-1-62703-218-6_16
Full text: Unavailable
Identification of antigenic peptides recognized by cytolytic T lymphocytes (CTL) is a prerequisite for the development of targeted cancer immunotherapy approaches. This chapter provides a global approach for the identification of peptides recognized by CTL. It implies the identification of the HLA molecule presenting the peptide as well as the design and screening of a cDNA library derived from the tumor cells.